EIEsra İsAt

Esra İsAt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esra İsAt has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evidence of docosahexaenoic acid deficiency in maple syrup urine disease: insights from plasma long-chain polyunsaturated fatty acid status

    by Tanyel Zubarioglu, Özgür Kasapçopur, Sedanur Akça-Yeşil, Esra İşAt, Mehmet Şerif Cansever, Ertuğrul Kıykım, Çiğdem Aktuğlu-Zeybek

    Background: Maple syrup urine disease (MSUD) is an inherited metabolic disorder requiring protein restriction, often limiting intake of animal-derived foods. This raises concerns about long-chain polyunsaturated fatty acid (LC-PUFA) status. The primary aim of this study is to evaluate plasma n–3 and n–6 fatty acid levels in MSUD patients. Methods: This single-center, cross-sectional study included 16 MSUD patients and 22 unaffected siblings sharing a similar household and environmental background. Dietary intake was recorded and plasma fatty acid profiles were analyzed. Results: Dietary assessments revealed significantly lower intakes of total fat and cholesterol (both p < 0.001) and n-3 PUFAs ( p = 0.036) in MSUD patients, with alpha-linolenic acid (ALA) intake as the only individual LC-PUFA significantly reduced ( p = 0.048). Plasma analysis showed significantly lower docosahexaenoic acid (DHA) levels in patients despite similar dietary DHA intake ( p < 0.001), while arachidonic acid and mead acid were significantly elevated (both p < 0.001). Although plasma DHA concentrations showed a moderate positive correlation with dietary ALA intake (r = 0.516, p = 0.041), regression analysis showed that neither dietary ALA intake (B = 0.005, p = 0.584) nor the dietary n-6/n-3 PUFA ratio (B = −0.552, p = 0.706) independently predicted plasma DHA levels. In the MSUD group, plasma DHA levels were positively associated with dietary leucine intake (r = 0.635, p = 0.008) and plasma isoleucine concentrations (r = 0.524, p = 0.037). Conclusion: Our findings provide evidence of DHA deficiency in MSUD patients, which may result from both inadequate dietary intake and changes in n-3 PUFA metabolism, highlighting the need to investigate additional contributing mechanisms.

  • Open Access

    Acute hepatic porphyria masquerading as familial Mediterranean fever: results of a cross-sectional porphobilinogen screening

    by Gulustan Musayeva, Esra İşAt, Mehmet Yıldız, Mehmet Şerif Cansever, Serdal Uğurlu, Dilek Uludağ Alkaya, Sezgin Şahin, Kenan Barut, Ertuğrul Kıykım, Çiğdem Aktuğlu-Zeybek, et al.

    Background: Acute hepatic porphyria (AHP) is a heme metabolism disorder characterized by acute abdominal pain episodes, with diagnostic delays and misdiagnosis due to heterogeneous presentations and symptom overlap with other diseases. Timely diagnosis is crucial as untreated attacks can lead to life-threatening complications such as hepatocellular carcinoma, chronic kidney disease, neuropathy and chronic pain. AHP often mimics various conditions such as lead poisoning, Guillain-Barré syndrome, vasculitis and surgical abdominal conditions, leading to diagnostic challenges and inappropriate treatment. Familial Mediterranean fever (FMF), another disease with recurrent abdominal pain as its main feature, has a similar symptomatology to AHP. The aim of this study was to investigate the prevalence of AHP in patients with clinically suspected FMF without a confirmatory genotype using cross-sectional urinary porphobilinogen (PBG) screening during abdominal pain episodes. Results: This cross-sectional study included a total of 104 patients under rheumatology follow-up for suspected FMF and two control groups (genetically confirmed FMF patients and healthy controls). Patients presenting with severe abdominal pain and had a spot urinary PBG/creatinine ratio of ≥ 10 µmol/mmol were diagnosed with AHP together with at least one clinical manifestation defined by the European Porphyria Network. Among 104 suspected-FMF patients, 5 (4.8%) were diagnosed with AHP, with a diagnostic delay of 16.4 ± 10.38 years. AHP patients frequently exhibited neurological (muscle weakness, paresthesia), psychiatric, and gastrointestinal (nausea, vomiting) symptoms. In likelihood ratio analyses, urinary incontinence, hypertension and neuropathic symptoms were strong discriminative indicators of AHP, whereas fever, arthritis, rash and chest pain were more indicative of FMF, aiding differential diagnosis. Conclusions: Due to diagnostic challenges and overlapping symptoms, AHP should be considered in the differential diagnosis of FMF, particularly in patients with neurological or systemic features. Urinary PBG screening and identifying predictive markers may improve diagnostic accuracy and early management of AHP.

  • Open Access

    Plasma sterol profiling in autism spectrum disorder: insights from cerebrotendinous xanthomatosis screening and beyond

    by Kagan Calisgan, Tanyel Zubarioglu, Esra İsAt, Hanim Babazade, Sedanur Akca-Yesil, Selin Akbulut, Esma Uygur, Vildan Keskin, Busra Cirkin, Gizem Durcan, et al.

    Cerebrotendinous xanthomatosis (CTX) is a rare, treatable bile acid synthesis disorder characterized by increased levels of cholestanol. Studies indicate that autism spectrum disorder (ASD) may be an early manifestation of CTX. Independent of CTX, disturbances in sterol and bile acid metabolism are observed in ASD. Therefore, this study aimed to estimate the prevalence of CTX in a pediatric ASD cohort using cholestanol-based screening with reflex CYP27A1 sequencing and to compare plasma sterol profiles among children with ASD. We conducted a single-center, cross-sectional study including 103 patients with ASD and 70 age-matched, normally developed children. Fasting plasma cholestanol, campesterol, stigmasterol and sitosterol were quantified by gas chromatography/mass spectrometry. Participants with cholestanol ≥ 7 µg/ml underwent CYP27A1 sequencing, and five-day dietary recalls were analyzed in 75 ASD participants. Elevated cholestanol was observed in 27 of 103 patients with ASD (26.2%) but in none of the controls ( p < 0.001). No participant had biallelic pathogenic CYP27A1 variants; one heterozygous variant of uncertain significance was detected. Median concentrations of cholestanol, campesterol, sitosterol and stigmasterol were significantly higher in patients with ASD than in controls (all p ≤ 0.001), and sterol fractions were strongly correlated (cholestanol–campesterol r = 0.74, p < 0.001). In summary, no cases of CTX were identified in this cohort, suggesting that cholestanol-based screening in unselected ASD populations may have limited yield, particularly in the absence of additional clinical features suggestive of CTX. Nevertheless, the elevated plasma sterol levels in ASD patients suggest dysregulated sterol and bile acid homeostasis, warranting further investigation.

  • 02/06/2014 Düzenlenme Tarihli Olduğu Bildirilen Makine Satış Sözleşmesindeki İmzaların 14/02/2023 Tarihinde Yapılan İncelemesinde 10-16 ay İçerisindeki Bir Döneme Ait Olabileceğinin Kimyasal Değerlendirme İle Tespit Edilmesi: Mürekkep Yaşı Analizi Olgusu

    by Rıza Yılmaz, Esra İşAt, Kaan Keçeci, Salih Cengiz

    Adli belge incelemelerinde, imza aidiyetinin yanı sıra belgelerin oluşturulma tarihi de soruşturulabilmektedir. Bu çalışmada, bir makine satış sözleşmesindeki imzaların düzenleme tarihi olan 02/06/2014 ile aynı zamanda atılıp atılmadığı ve/veya ne kadar süre önce atıldığı veya sonra atıldığı sorulan bir olgu, mürekkep yaş tayini yöntemiyle belirlenmeye çalışılmıştır.Sonuç olarak mürekkep yaş tayininde alınan sonuçlarda sapmalara neden olabilecek normal saklama (arşiv, kasa, dolap, çekmece) koşulların dışındaki çevresel koşullar ve kağıdın türü gibi faktörlerin neden olabileceği hata paylarını da dikkate alarak yaş eğrileri üzerinden bir nokta seçerek kesin yaş belirlemek yerine 6 aylık zaman dilimleri ile yazı yaşını mutalaa etmek, uzmanın yanlış belirleme riskini ortadan kaldırabilecektir. In questioned document examinations, the date of creation of documents can be investigated as well as signature attribution. In this study, the ink age determination method was used to determine whether the signatures on a machine sales contract were made at the same time as 02/06/2014, the date of issue, and/or how long ago or after the date of issue.As a result, considering the margins of error that may be caused by factors such as environmental conditions outside of normal storage (archive, safe, cabinet, drawer) conditions and the type of paper that may cause deviations in the results obtained in ink age determination, instead of determining the exact age by selecting a point on the age curves, considering the age of the writing with 6-month time periods will eliminate the risk of the expert making a wrong determination.

  • Open Access

    Olgularla Adli Belge İnceleme

    by Bekir Karaman, İsmail Birincioğlu, Yasemin Yılmaz, Salih Cengiz, Berna Şenel Eraslan, Dilara Öner Kaya, Gürsel Çetin, Sermet Koç, Elife Kara, Hüseyin Şahin, et al.

    Boş Kağıda Atılmış Bir İmzadan Faydalanılarak Yapılan Sahtecilik Olgusu: Fiziksel İnceleme İle Bir Belgedeki İmzanın Yazıdan Önce Mevcut Olduğunun Adli Belge İnceleme Açısından Değerlendirilmesi Rıza YILMAZ Bekir KARAMAN İsmail BİRİNCİOĞLU Kaçınma Refleksi Yöntemi ile Adli Belgede Sahteciliğin Tespiti: Olgu Sunumu Rıza YILMAZ Bekir KARAMAN 13.12.2018 Düzenlenme Tarihli Olduğu Bildirilen Bir Senetteki Yazıların 31 Temmuz 2023 Tarihinde Yapılan İncelemesinde En Fazla 2 Yıl Öncesine Ait Olabileceğinin Kimyasal Değerlendirme ile Tespit Edilmesi: Başka Bir Amaçla Elde Edilen Bir İmzadan Yola Çıkılarak Düzenlenen Senet Olgusu Rıza YILMAZ Bekir KARAMAN Yasemin YILMAZ Salih CENGİZ Kendisinin Haberi Olmadan Yeni Bir Telefon Hattı Açıldığı İddiası İle Suç Duyurusunda Bulunan Kişinin Dijital Karşılaştırma İmzaları ve Dijital İnceleme Konusu İmzasının Dijital İnceleme Kriterleri Yönü ile Değerlendirilmesi: Olgu Sunumu Rıza YILMAZ Bekir KARAMAN Yasemin YILMAZ Olgular Eşliğinde Kaşe İmza Kavramı Berna ŞENEL ERASLAN Dilara ÖNER KAYA Gürsel ÇETİN Sermet KOÇ Pencere Yöntemi Sahteciliği Suretiyle Başka Amaçla Atılan İmzadan Senet Oluşturulmasının Adli Belge İnceleme Açısından Değerlendirilmesi: Olgu Sunumu Elife KARA - Hüseyin ŞAHİN - Kirman YOLCU Ali ÖZTÜRK - Bekir KARAMAN - Rıza YILMAZ İsmail BİRİNCİOĞLU İmzanın Belgeye Autopen Benzeri Bir Cihaz ile Transferi-Olgu Sunumu Yasin KOCA Berna ŞENEL ERASLAN Elnar MAMMADOV Sermet KOÇ Tetabuk Şeklinde İmza Sahteciliği: İnceleme Konusu Belgenin Faks Çıktısı Fotokopisi Olduğu Bir Olgu Sunumu Hasan OKUMUŞ İsmail BİRİNCİOĞLU Bekir KARAMAN Rıza YILMAZ Bir Olgu Üzerinden İmzalarda Zaman İçerisinde Meydana Gelen Değişiklik Mi, Ortopedik Bir Hastalığa Bağlı İmza Farklılığı Mı ya da Huzurda Atılan İmzanın Bilinçli Olarak Farklı Şekilde Değiştirilmesi Mi? Bekir KARAMAN Rıza YILMAZ İsmail BİRİNCİOĞLU Bir Çekin Keşide Tarihi Üzerinden Birden Fazla Gidilmesi Sonrası Oluşan Değişikliğin (Sürşarjın) Adli Belge İncelemeciliği Açısından Değerlendirilmesi: Olgu Sunumu Bekir KARAMAN Rıza YILMAZ Yasemin YILMAZ 02/06/2014 Düzenlenme Tarihli Olduğu Bildirilen Makine Satış Sözleşmesindeki İmzaların 14/02/2023 Tarihinde Yapılan İncelemesinde 10-16 ay İçerisindeki Bir Döneme Ait Olabileceğinin Kimyasal Değerlendirme İle Tespit Edilmesi: Mürekkep Yaşı Analizi Olgusu Rıza YILMAZ Esra İŞAT Kaan KEÇECİ Salih CENGİZ İlk Bakışta Birbirine Benzer Gibi Görülen İnceleme Ve Karşılaştırma Konusu İmzalar, Aynı Elin Ürünü Mü Yoksa İyi Bir Taklit Mi?; Olgunun Adli Belge İncelemeciliğinin Bazı Özellikleri İle Değerlendirilmesi Rıza YILMAZ Bekir KARAMAN İsmail BİRİNCİOĞLU Tehdit Mektubu Olarak Yazılan ve Nadiren Görülen Duvar Yazısının Adli Belge İncelemeciliği Açısından Değerlendirilmesi Bekir KARAMAN Rıza YILMAZ Yasemin YILMAZ Yaşlılık ve İmza Değişimi Salim YAREN Nergis CANTÜRK Sahte Olarak Düzenlendiği Bildirilen Hafızlık Belgesinde İğfalkabiliyetinin (Aldatma Gücünün) Olup Olmamasının Adli Belge İncelemeciliği Açısından Değerlendirilmesi: Olgu Sunumu Rıza YILMAZ Bekir KARAMAN Hukuki Ehliyetin İmza İncelemesi Yönüyle Değerlendirilmesi: Olgu Sunumu Bekir KARAMAN Rıza YILMAZ Hasan BUDAK Özlem EREL Yabancı Uyruklularda Olgularla İmza İnceleme Aysun BARANSEL ISIR Hasret Can KARATAŞ Tamer ISIR Murat AKBABA

  • Open Access

    Analysis of Biotinidase Activity in Serum by Digital Imaging Colorimetry Detection

    by Orhan Destanoğlu, M. Şerif Cansever, Esra İşat, Tanyel Zübarioğlu, A. Çiğdem Aktuğlu Zeybek, Ertuğrul Kıykım

    Biotinidase deficiency (BD) is an autosomal recessive inherited disorder of biotin recycling that leads to neurological and cutaneous consequences if left untreated. The clinical features of BD can be ameliorated or prevented by the administration of pharmacological doses of the vitamin biotin. Since it is a treatable disorder, BD is included in the newborn screening program in Turkiye as in many other countries. Therefore, monitoring of biotinidase enzyme activity (BEA) is of vital importance, especially for patients. The aim of this study was to develop a simple and reliable colorimetric method based on digital imaging for the analysis of BEA in serum samples. To determine the optimum distance and LED light source in the analyzer box that we fabricated in the laboratory, images of the solutions in a 96-well microplate were taken with a mobile phone camera, and each color space was examined. The most reliable relationship was between blank subtracted intensities of green channel and analyte concentrations, which was in the range of 35-400 ng/mL p-aminobenzoic acid (r(2 )= 0.999). The limit of detection and limit of quantification were 11 and 35 ng/mL, respectively. The proposed method was successfully applied to serum samples of 60 patients with BD and 60 healthy controls. We claim that the method can be easily performed for determination of BEA anywhere without needing expensive instruments.


  • Urinary neopterin and biopterin indicate that inflammation has a role in autism spectrum disorder

    by Ece Oge-Enver, Esra Isat, Mehmet Serif Cansever, Tanyel Zubarioglu, Gizem Yilmaz, Memnune Nur Cebi, Cigdem Aktuglu-Zeybek, Ertugrul Kiykim

    Inflammation is thought to be involved in the pathogenesis of autism spectrum disorder (ASD). Pteridine metabolites are biomarkers of inflammation that increase on immune system activation. In this study, we investigated the urinary pteridine metabolites in ASD patients as a possible biomarker for immune activation and inflammation. This observational, cross-sectional, prospective study collected urine samples from 212 patients with ASD and 68 age- and sex-matched healthy individuals. Urine neopterin (NE) and biopterin (BIO) levels were measured. Patients who had chronic disorders, active infection at the time of sampling, or high C-reactive protein levels were excluded. The urine NE and BIO concentrations were determined by high-performance liquid chromatography. The ratios of both NE and BIO to creatinine (CRE) were used to standardise the measurements. The NE/CRE and NE/BIO levels were significantly higher in ASD patients than controls. Univariate and multivariate models revealed a significant increase in NE/CRE and NE/BIO in ASD patients. There was a significant relationship between the NE/BIO [average area under the curve (AUC) = 0.717; range: 0.637–0.797] and NE/CRE (average AUC = 0.756; range: 0.684–0.828) ratios, which distinguished individuals with ASD from controls. The elevated NE/CRE and NE/BIO ratios suggest that inflammation and T cell-mediated immunity are involved in the pathophysiology of autism. NE/BIO could serve as a diagnostic inflammatory marker in the pathogenesis of ASD.